Optimal selection of radiotherapy as part of a multimodal approach for hepatocellular carcinoma

Hong In Yoon, Jinsil Seong

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

A multimodal approach to treatment is a basic oncologic principle with proven survival benefits for most cancer types. However, existing guidelines recommend single modalities for treating each stage of hepatocellular carcinoma (HCC). Nonetheless, multimodal approaches can be considered for HCC, depending on the characteristics of the disease in individual cases. Radiotherapy (RT), an effective local modality, is a critical element of most multimodal approaches. Improved RTtechnology and increased understanding of the tolerance of the liver to radiation have contributed to the popularity of RT for treating liver tumors in clinical practice. Consequently, numerous reports have described the effects of RT on liver cancer, despite a lack of stringent evidence for its benefits. RT can be delivered using various technologies and approaches, which may be the source of some confusion. For example, high-dose ablative RT can be curative on its own, or high-dose ablative or conventional RT can complement other treatments such as radiofrequency ablation and transarterial chemoembolization. Combinations of systemic agents and RT can also be applied. This review discusses the optimal selection of RT as part of a multimodal approach for HCC.

Original languageEnglish
Pages (from-to)139-151
Number of pages13
JournalLiver Cancer
Volume5
Issue number2
DOIs
Publication statusPublished - 2016 Apr 1

Fingerprint

Hepatocellular Carcinoma
Radiotherapy
Liver
Liver Neoplasms
Neoplasms
Guidelines
Radiation
Technology
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Oncology

Cite this

@article{44a14db5dd174bbb85578436bc9e5dd5,
title = "Optimal selection of radiotherapy as part of a multimodal approach for hepatocellular carcinoma",
abstract = "A multimodal approach to treatment is a basic oncologic principle with proven survival benefits for most cancer types. However, existing guidelines recommend single modalities for treating each stage of hepatocellular carcinoma (HCC). Nonetheless, multimodal approaches can be considered for HCC, depending on the characteristics of the disease in individual cases. Radiotherapy (RT), an effective local modality, is a critical element of most multimodal approaches. Improved RTtechnology and increased understanding of the tolerance of the liver to radiation have contributed to the popularity of RT for treating liver tumors in clinical practice. Consequently, numerous reports have described the effects of RT on liver cancer, despite a lack of stringent evidence for its benefits. RT can be delivered using various technologies and approaches, which may be the source of some confusion. For example, high-dose ablative RT can be curative on its own, or high-dose ablative or conventional RT can complement other treatments such as radiofrequency ablation and transarterial chemoembolization. Combinations of systemic agents and RT can also be applied. This review discusses the optimal selection of RT as part of a multimodal approach for HCC.",
author = "Yoon, {Hong In} and Jinsil Seong",
year = "2016",
month = "4",
day = "1",
doi = "10.1159/000367762",
language = "English",
volume = "5",
pages = "139--151",
journal = "Liver Cancer",
issn = "2235-1795",
publisher = "S. Karger AG",
number = "2",

}

Optimal selection of radiotherapy as part of a multimodal approach for hepatocellular carcinoma. / Yoon, Hong In; Seong, Jinsil.

In: Liver Cancer, Vol. 5, No. 2, 01.04.2016, p. 139-151.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Optimal selection of radiotherapy as part of a multimodal approach for hepatocellular carcinoma

AU - Yoon, Hong In

AU - Seong, Jinsil

PY - 2016/4/1

Y1 - 2016/4/1

N2 - A multimodal approach to treatment is a basic oncologic principle with proven survival benefits for most cancer types. However, existing guidelines recommend single modalities for treating each stage of hepatocellular carcinoma (HCC). Nonetheless, multimodal approaches can be considered for HCC, depending on the characteristics of the disease in individual cases. Radiotherapy (RT), an effective local modality, is a critical element of most multimodal approaches. Improved RTtechnology and increased understanding of the tolerance of the liver to radiation have contributed to the popularity of RT for treating liver tumors in clinical practice. Consequently, numerous reports have described the effects of RT on liver cancer, despite a lack of stringent evidence for its benefits. RT can be delivered using various technologies and approaches, which may be the source of some confusion. For example, high-dose ablative RT can be curative on its own, or high-dose ablative or conventional RT can complement other treatments such as radiofrequency ablation and transarterial chemoembolization. Combinations of systemic agents and RT can also be applied. This review discusses the optimal selection of RT as part of a multimodal approach for HCC.

AB - A multimodal approach to treatment is a basic oncologic principle with proven survival benefits for most cancer types. However, existing guidelines recommend single modalities for treating each stage of hepatocellular carcinoma (HCC). Nonetheless, multimodal approaches can be considered for HCC, depending on the characteristics of the disease in individual cases. Radiotherapy (RT), an effective local modality, is a critical element of most multimodal approaches. Improved RTtechnology and increased understanding of the tolerance of the liver to radiation have contributed to the popularity of RT for treating liver tumors in clinical practice. Consequently, numerous reports have described the effects of RT on liver cancer, despite a lack of stringent evidence for its benefits. RT can be delivered using various technologies and approaches, which may be the source of some confusion. For example, high-dose ablative RT can be curative on its own, or high-dose ablative or conventional RT can complement other treatments such as radiofrequency ablation and transarterial chemoembolization. Combinations of systemic agents and RT can also be applied. This review discusses the optimal selection of RT as part of a multimodal approach for HCC.

UR - http://www.scopus.com/inward/record.url?scp=85006257087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006257087&partnerID=8YFLogxK

U2 - 10.1159/000367762

DO - 10.1159/000367762

M3 - Review article

VL - 5

SP - 139

EP - 151

JO - Liver Cancer

JF - Liver Cancer

SN - 2235-1795

IS - 2

ER -